The Precision Peptide Genetic Test reveals predispositions in GIPR, and metabolic genes that may provide context for baseline receptor function
Novo joins Lilly in asking FDA for ban on GLP-1 compounding Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers
In addition, with the increased strength creatine provides, heavier weights can be used in the gym which provide more stimulus for growth, consequently increasing muscle accrual in the long-term
Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, et al
However, given the scarcity of studies, this pattern must be interpreted cautiously
SeekPeptides members gain access to comprehensive protocol builders that go beyond simple dose calculations